NASDAQ

Taysha Gene Therapies, Inc. (TSHA)

♥ 568 Thanks from members

Live price chart, market sentiment, and community perspectives for Taysha Gene Therapies, Inc. (NASDAQ: TSHA).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: RA Capital ManagementFounder: Jerel DavisLeadership: Sean Nolan (CEO)Leadership: Andrew Robbins (CFO)Holder: RA Capital ManagementHolder: Fidelity Management and ResearchHolder: Deep Track CapitalTSHA-102 (Rett Syndrome Gene Therapy)TSHA-120#TSHA#Taysha Gene Therapies#Gene therapy stock#CNS disorders#NASDAQ TSHA